Research & Development

ReAlta's R&D Focuses on Three Major Therapeutic Areas

ReAlta’s efforts are focused on developing therapies that leverage our unique dual targeting mechanisms in three therapeutic areas: Neurology, Pulmonary, and Hematology.

Hypoxic Ischemic Encephalopathy

Hypoxic-ischemic encephalopathy (HIE) is a type of newborn brain damage caused by oxygen deprivation and limited blood flow.

Learn More
Acute Lung Injury

Acute lung injury (ALI) is the pulmonary manifestation of an acute systemic inflammatory process characterized clinically by pulmonary infiltrates, hypoxemia and edema.

Learn More
Platelet Transfusion Reaction

Platelet transfusion reaction is a serious, life threatening event that can occur when a patient fails to stabilize platelet levels after a blood transfusion.

Learn More
Clinical Pipeline

Our Three Major Therapeutic Areas

Pipeline 6.1